NO993684L - Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II - Google Patents

Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II

Info

Publication number
NO993684L
NO993684L NO993684A NO993684A NO993684L NO 993684 L NO993684 L NO 993684L NO 993684 A NO993684 A NO 993684A NO 993684 A NO993684 A NO 993684A NO 993684 L NO993684 L NO 993684L
Authority
NO
Norway
Prior art keywords
amino acid
stands
residue
gly
peptides
Prior art date
Application number
NO993684A
Other languages
English (en)
Other versions
NO993684D0 (no
Inventor
Sinasi Bayrak
Rikard Holmdahl
Avrion Mitchison
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO993684D0 publication Critical patent/NO993684D0/no
Publication of NO993684L publication Critical patent/NO993684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer et isolert peptid som omfatter en aminosyrese- kvens med formelen (I) A,-Xaa-Gly-A4-A5-Gly-A7-Xaa-Gly, hvori A, står for en ami- nosyrerest med en aromatisk eller alifatisk sidekjede, A4 står for en asparagin- eller ar- gininrest eller en aminosyrerest med en aromatisk eller alifatisk sidekjede, A5 står for enhver naturlig forekommende aminosyre, A7 står for en aminosyre med en negativt ladet rest, Xaa står for enhver aminosyrerest, og Gly står for en glysinrest; og anvendel- sen av slike peptider i medisinsk terapi, spesielt i behandlingen av autoimmune tilstan- der slik som reumatoid artritt.
NO993684A 1997-01-31 1999-07-29 Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II NO993684L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700301A SE9700301D0 (sv) 1997-01-31 1997-01-31 New compound
PCT/SE1998/000128 WO1998033811A1 (en) 1997-01-31 1998-01-29 Peptides comprising a t-cell epitope specific to collagen ii

Publications (2)

Publication Number Publication Date
NO993684D0 NO993684D0 (no) 1999-07-29
NO993684L true NO993684L (no) 1999-09-02

Family

ID=20405590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993684A NO993684L (no) 1997-01-31 1999-07-29 Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II

Country Status (19)

Country Link
EP (1) EP1007547A1 (no)
JP (1) JP2001511143A (no)
KR (1) KR20000070542A (no)
CN (1) CN1246125A (no)
AU (1) AU744907B2 (no)
BR (1) BR9811250A (no)
CA (1) CA2278638A1 (no)
EE (1) EE9900334A (no)
HU (1) HUP0000836A3 (no)
ID (1) ID22802A (no)
IL (1) IL131045A0 (no)
IS (1) IS5138A (no)
NO (1) NO993684L (no)
NZ (1) NZ336745A (no)
PL (1) PL334877A1 (no)
SE (1) SE9700301D0 (no)
SK (1) SK102199A3 (no)
TR (1) TR199901831T2 (no)
WO (1) WO1998033811A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO571297A0 (en) * 1997-03-19 1997-04-10 Montech Medical Developments Pty Ltd Method for the diagnosis of rheumatoid arthritis
CA2452593C (en) * 2001-07-12 2015-02-03 Arexis Ab Triple polypeptide complexes
CN100346823C (zh) * 2001-09-14 2007-11-07 比奥拉比奥埃克斯公司 用于调节免疫反应的釉质基质蛋白组合物
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
KR20170002734U (ko) 2016-01-21 2017-07-31 김인수 자동 목재절단 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08151396A (ja) * 1994-11-28 1996-06-11 Teijin Ltd Ｈｌａ結合性オリゴペプチド及びそれを含有する免疫調節剤
AU4695296A (en) * 1995-01-06 1996-07-24 Immulogic Pharmaceutical Corporation Compositions and methods for treating rheumatoid arthritis

Also Published As

Publication number Publication date
EP1007547A1 (en) 2000-06-14
KR20000070542A (ko) 2000-11-25
AU744907B2 (en) 2002-03-07
ID22802A (id) 1999-12-09
HUP0000836A3 (en) 2001-04-28
NZ336745A (en) 2001-09-28
CN1246125A (zh) 2000-03-01
SK102199A3 (en) 2000-08-14
BR9811250A (pt) 2000-09-26
NO993684D0 (no) 1999-07-29
TR199901831T2 (xx) 1999-10-21
IL131045A0 (en) 2001-01-28
CA2278638A1 (en) 1998-08-06
SE9700301D0 (sv) 1997-01-31
JP2001511143A (ja) 2001-08-07
WO1998033811A1 (en) 1998-08-06
HUP0000836A2 (hu) 2000-11-28
IS5138A (is) 1999-07-28
EE9900334A (et) 2000-02-15
AU5889298A (en) 1998-08-25
PL334877A1 (en) 2000-03-27

Similar Documents

Publication Publication Date Title
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
EP0333356A3 (en) Hirudin peptides
IE831909L (en) Molecular cloning and characterization of a gene cloning for¹human relaxin
FI961044A0 (fi) Kininogeeni-inhibiittorit
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
NO993684L (no) Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
GB0210783D0 (en) Anti-microbial polypeptides
EP0917535A4 (en) NEURO-ACTIVE PEPTIDE
EP0837074A3 (en) Biologically active fibronectin fragment as cancer metastasis inhibitor
AU7196596A (en) Peptides and antibodies for treatment of rheumatoid arthritis
EP2143730A3 (en) Modified peptides and their use for the treatment of autoimmune diseases
IL122445A (en) Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis
NZ511747A (en) Regulatory/unfolding peptides of ezrin
NZ508812A (en) Peptides for the prevention or treatment of HIV
ATE393777T1 (de) Tachykininpeptide, ihre präpeptide und sie kodierende gene
AU2003303218A1 (en) Peptides and their use for the treatment of hiv infections
ATE305478T1 (de) Topoisomerase-ii inhibitoren
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide
AU1971899A (en) Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
HUP9902937A2 (hu) Rheumatoid artritisz patogenezisében szerepet játszó artritogén peptidekkel szemben immunvédettséget kiváltó vakcinakészítmények és eljárás ilyen védettség létrehozására
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application